Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 243-654-4 | CAS number: 20262-76-4
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Results of available in vitro studies:
- Ames test for the strain TA 98 in the presence of metabolic activation S9 at 5000 µg/plate: positive.
- mammalian cell gene mutation test: negative.
- Ames test for the strain TA 98 in presence and absence of metabolic activation S9 at 5000 µg/plate: negative.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Description of key information
Results of available in vitro study:
Single cell gel/Comet assay in rats: negative.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Based on in vitro gene mutation study in bacteria, E131 Patent blue V sodium salt induces biologically significant increases in the number of revertants in the strain TA98 in the presence of metabolic activation at 5000 µg/plate. Anyway, EFSA noted that the positive outcome obtained in the presence of metabolic activation at higher dose levels, strongly indicates that mutagenicity may derive from the presence of impurities. In fact, this test was repeated on strain TA98 with and without metabolic activation at 5000 µg/plate and the result was negative. The test item does not show any potential for genetic toxicity.
The in vitro gene mutation study in mammalian cells showed no mutagenic potential at doses up to 2500 μg/ml. Therefore, EFSA considered the results of this assay inconclusive since the upper limit of concentration (5000 μg/ml) indicated by the relevant OECD guideline (OECD 476) was not tested.
The DNA damaging capabilities of the test item were assessed in the in vivo single cell gel/Comet assay in rats. In this study it concluded that E131 Patent Blue V induced no effect on DNA migration in rat liver, jejunum/ileum and peripheral blood after in vivo treatment.
Justification for classification or non-classification
Not classified for genetic toxicity according to the CLP Regulation (EC.1272/2008). For justification see additional information.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
